Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Nirsevimab for RSV Prevention in Late Preterm and Term Infants | NEJM
2022
· NEJM Group
This short video summarizes new research findings on nirsevimab and how it can prevent RSV in late preterm and term infants. The trial included 1490 …
Ask aRCie
The Assessment of Future RSV Immunizations: How to Protect All Infants?
2022
· University Medical Centre Utrecht,
· Paris Cité University,
· University of Lübeck,
· University of Parma,
· Comunidad de Madrid,
· Università Degli Studi Di Milano Statale,
· European Foundation for the Care of Newborn Infants (EFCNI),
· Nihon University School of Medicine,
· Beijing Children's Hospital,
· University of Thessaly,
· University of Southampton,
· University Hospital Southampton NHS Foundation Trust,
· Bambino Gesù Children Hospital
This article explores ways to protect infants from RSV, a common virus that can cause serious illness. It describes different immunization strategies being developed to …
The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
This article discusses the significant burden of respiratory syncytial virus (RSV) in infants in the United States. It covers the epidemiology, hospitalization rates, mortality, costs, …
Challenges in Maximizing Impacts of Preventive Strategies Against Respiratory Syncytial Virus (RSV) Disease in Young Children
2022
· Yale University
This article discusses the challenges and advancements in preventive strategies against Respiratory Syncytial Virus (RSV) disease in young children. RSV is a common cause of …
Monoclonal Antibodies for Prophylaxis and Treatment of Respiratory Viral Infections
This article discusses the use of monoclonal antibodies (mAbs) to prevent and treat respiratory viral infections, especially in people with weak immune systems. It describes …
Monoclonal Antibody 75% Effective in Infants Against Respiratory Viral Infection
2022
This article describes a study on nirsevimab, a monoclonal antibody that could protect infants from RSV infections. The study involved 1,490 infants and showed that …
Nirsevimab Reduces Medically Attended RSV-Associated Lower Respiratory Tract Infection and Hospitalisations in Healthy Pre-Term Infants
2022
· University College Cork
This article comments on a study on how nirsevimab helps reduce RSV-related lung infections and hospital visits in healthy pre-term infants. It highlights the benefits …